Kidney Foundation;
rights Home hemodialysis;
AAKHI;
TCU;
HHD infrastructure;
Patient education;
LEFT-VENTRICULAR HYPERTROPHY;
QUALITY-OF-LIFE;
PERITONEAL-DIALYSIS;
INTENSIVE HEMODIALYSIS;
NEPHROLOGY FELLOWSHIP;
CARE;
D O I:
10.1053/j.ackd.2021.06.009
中图分类号:
R5 [内科学];
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号:
1002 ;
100201 ;
摘要:
The Advancing American Kidney Health Initiative has set an aggressive target for home dialysis growth in the United States, and expanding both peritoneal dialysis and home hemodialysis (HHD) will be required. While there has been a growth in HHD across the United States in the last decade, its value in controlling specific risk factors has been underappreciated and as such its appropriate utilization has lagged. Repositioning how nephrologists incorporate HHD as a critical renal replacement therapy will require overcoming a number of barriers. Advancing education of both nephrology trainees and nephrologists in practice, along with increasing patient and family education on the benefits and requirements for HHD, is essential. Implementation of a transitional care unit design coupled with an intensive patient curriculum will increase patient awareness and comfort for HHD; patients on peritoneal dialysis reaching a modality transition point will benefit from Experience the Difference programs acclimating them to HHD. In addition, the potential link between HHD program size and patient outcomes will necessitate an increase in the size of the average HHD program to more consistently deliver quality dialysis results. Addressing the implications of the nursing shortage and need for designing in scope staffing models are necessary to safeguard HHD growth. Seemingly, certain government payment policy changes and physician documentation requirements deserve further examination. Future HHD innovations must result in decreasing the burden of care for HHD patients, optimize the level of device and biometric data flow, facilitate a more functional centralized patient management care approach, and leverage computerized clinical decision support for modality assignment. (c) 2021 by the National Kidney Foundation, Inc. All rights reserved.
机构:
Columbia Univ, Dept Med, Div Nephrol, New York, NY USAColumbia Univ, Dept Med, Div Nephrol, New York, NY USA
Groopman, Emily E.
Gharavi, Ali G.
论文数: 0引用数: 0
h-index: 0
机构:
Columbia Univ, Dept Med, Div Nephrol, New York, NY USA
Columbia Univ, Inst Genom Med, New York, NY USAColumbia Univ, Dept Med, Div Nephrol, New York, NY USA
机构:
Rovira I Virgili Univ, Dept Analyt Chem & Organ Chem, Lab Sustainable Polymers, Tarragona 43007, SpainRovira I Virgili Univ, Dept Analyt Chem & Organ Chem, Lab Sustainable Polymers, Tarragona 43007, Spain
Moreno, Adrian
Sipponen, Mika H.
论文数: 0引用数: 0
h-index: 0
机构:
Stockholm Univ, Dept Mat & Environm Chem, SE-10691 Stockholm, Sweden
Stockholm Univ, Wallenberg Wood Sci Ctr, Dept Mat & Environm Chem, SE-10691 Stockholm, SwedenRovira I Virgili Univ, Dept Analyt Chem & Organ Chem, Lab Sustainable Polymers, Tarragona 43007, Spain